Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 984 | 989 | 998 | 1002 | 1059 | 1421 |
Fund Return | -1.63% | -1.14% | -0.18% | 0.08% | 1.15% | 3.57% |
Place in category | 108 | 97 | 99 | 86 | 62 | 19 |
% in Category | 91 | 82 | 88 | 88 | 89 | 82 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PIMegatrend Selection I USD | 11.98B | 11.50 | 1.48 | 8.15 | ||
PIMegatrend Selection P dy USD | 11.98B | 10.76 | 0.57 | 7.23 | ||
PIMegatrend Selection R USD | 11.98B | 10.01 | -0.33 | 6.27 | ||
PIMegatrend Selection Z USD | 11.98B | 12.33 | 2.49 | 9.23 | ||
Pictet Global Megatrend Selection P | 11.98B | 10.76 | 0.57 | 7.23 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet TR Agora HP USD | 60.27M | -1.99 | -0.45 | 3.09 | ||
Schroder Euro Alpha AR C AccUSD H | 37.17M | 5.16 | -0.91 | 1.19 | ||
Schroder Euro Alpha AR A AccUSD H | 37.17M | 4.80 | -1.71 | 0.29 | ||
Schroder Euro Alpha AR B AccUSD H | 37.17M | 4.40 | -2.22 | -0.20 | ||
BlackRock Strats GlblLongShortEqA2 | 22.25M | 14.50 | 7.36 | 3.13 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Pictet-Short-Term Money Market EUR Z | LU0222474503 | 8.17 | - | - | |
Novo Nordisk B | DK0062498333 | 0.56 | 730.0 | -2.60% | |
Syensqo | BE0974464977 | 0.20 | 80.52 | +1.47% | |
CFD on Galderma Group AG Registered Shares | - | 0.10 | - | - | |
CFD on Experian PLC | - | 0.09 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Sell | Sell |
Technical Indicators | BUY | Strong Sell | Strong Sell |
Summary | Neutral | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review